{"nct_id":"NCT04737330","title":"A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)","status":"TERMINATED","status_verified_date":"2024-12","start_date":"2021-11-29","start_date_type":"ACTUAL","primary_completion_date":"2023-05-16","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}